4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-011175
SVP, Head of Global Commercial sold 5,909 shares at $40.00 ($236,360)
- SVP, Head of Global Commercial acquired 4,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Porter Derrell SVP, Head of Global Commercial | 2019-02-15 | Option exercise | +4,000 | $14.30 | $57,200 | 27,597 | D |
| Porter Derrell SVP, Head of Global Commercial | 2019-02-15 | Sale | −5,909 | $40.00 | $236,360 | 21,688 | D |
| Derivatives | |||||||
| Porter Derrell SVP, Head of Global Commercial | 2019-02-15 | Option exercise · Employee Stock Option (Right to Buy) | −4,000 | 109,666 | D | ||
| Open-market sales · 5,909 sh · avg $40.00 · $236,360 | |||||||
Loading xslF345X03/doc4.xml…